Brief: NuCana Q2 EPS GBP 0
UK's NuCana Q1 net loss widens; cash runway extends to 2029
UK's NuCana Q4 net loss widens
Brief: NuCana Reinstates Hugh Griffith as CEO and Chief Executive Officer
NuCana Q3 net loss narrows
Brief: Nucana Says Data From Nutide:701 Shows Favorable Safety And Tumor Reduction
Brief: NuCana To Implement ADS Ratio Change Of 1 ADS to 5,000 Ordinary Shares
Brief: Nucana Says May Offer And Sell ADSs Of Up To $100 Million From Time To Time
Brief: Nucana's CEO Hugh S.Griffith Will Be Taking A Leave Of Absence Due To Health Reasons
Brief: NuCana Q1 EPS GBP -0.02
Brief: Nucana Reports Fourth Quarter And Year-End 2024 Financial Results And Provides Business Update
Brief: Nucana PLC's Donald Munoz Departs From His Role As CFO
Brief: Nucana Reports Q3 2024 Financial Results And Provides Business Update
NuCana PLC expected to post a loss of £2.67 a share - Earnings Preview
Brief: NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the US
NuCana falls after co discontinues colorectal cancer study
NuCana PLC reports results for the quarter ended in June - Earnings Summary
Brief: NuCana Files For Mixed Shelf Offering Of Up To $150 Mln
NuCana PLC expected to post a loss of £1.81 a share - Earnings Preview